NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit
U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention
Avastin Improves PFS In Advanced Breast Cancer
Preoperative Drug Combo Benefits HER-2 Breast Cancer
Combination Radiation/Vaccine May Benefit Some Patients
“Inoperable” Prostate Cancer May Be Operable, Curable
Benefit Seen In Novel Drug That Treats Gleevec Resistance
NCI’s Rosenberg Confirms 2002 Immunotherapy Results
NCI-Approved Clinical Trials
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?
